Search

27371 results found for *.

3401. Open Executive Session to Consider Favorably Reporting Pending Nominations
      06/28/2018

      Open Executive Session to Consider Favorably Reporting Pending Nominations

3402. Hearing to Consider the Nomination of Charles P. Rettig, of California, to be Commissioner of Internal Revenue for the Term Expiring November 12, 2022
      06/28/2018

      Hearing to Consider the Nomination of Charles P. Rettig, of California, to be Commissioner of Internal Revenue for the Term Expiring November 12, 2022

3403. Wyden Statement at Finance Committee Hearing to Consider the Nomination of Charles P. Rettig to be IRS Commissioner
      06/28/2018

      Wyden Statement at Finance Committee Hearing to Consider the Nomination of Charles P. Rettig to be IRS Commissioner

3404. Wyden Statement at Finance Committee Markup of ACF, Commerce, and Tax Court Nominations
      06/28/2018

      Wyden Statement at Finance Committee Markup of ACF, Commerce, and Tax Court Nominations

3405. Hatch Announces New Finance Committee Majority Staff Director
      06/28/2018

      Hatch Announces New Finance Committee Majority Staff Director

3406. Finance Committee Advances Commerce, HHS & Tax Court Nominees
      06/28/2018

      Finance Committee Advances Commerce, HHS & Tax Court Nominees

3407. Hatch Opening Statement at Rettig Nomination Hearing
      06/28/2018

      Hatch Opening Statement at Rettig Nomination Hearing

3408. Hatch Statement on Administration’s Investment Restrictions Announcement
      06/27/2018

      Hatch Statement on Administration’s Investment Restrictions Announcement

3409. Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market
      06/26/2018

      Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market

3410. Wyden Statement at Finance Committee Hearing on the President’s Drug Blueprint
      06/26/2018

      Wyden Statement at Finance Committee Hearing on the President’s Drug Blueprint